CRISPR-Cas9 screen reveals that inhibition of enhancer of zeste homolog 2 sensitizes malignant T cells to dimethyl-fumarate-induced cell death

Constitutive activation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway is a hallmark of many lymphocyte-associated cancers, including cutaneous T-cell lymphoma (CTCL) and its leukemic variant, the Sézary syndrome. Dimethyl fumarate (DMF) has been identified as...

Full description

Saved in:
Bibliographic Details
Main Authors: Teubner, Jan P. (Author) , Tümen, Deniz (Author) , Kandulski, Arne (Author) , Heumann, Philipp (Author) , Mester, Patricia (Author) , Aschenbrenner, Elisabeth (Author) , Pollinger, Kirstin (Author) , Gunckel, Manuela (Author) , Volz, Barbara (Author) , Hein, Tobias (Author) , Beltzig, Paul L. (Author) , Tengler, Luisa (Author) , Voll, Florian (Author) , Kreutz, Marina (Author) , Kunst, Claudia (Author) , Nicolay, Jan Peter (Author) , Müller-Schilling, Martina (Author) , Gülow, Karsten (Author)
Format: Article (Journal)
Language:English
Published: 2025
In: The FEBS journal
Year: 2025, Pages: 1-17
ISSN:1742-4658
DOI:10.1111/febs.70208
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1111/febs.70208
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/febs.70208
Get full text
Author Notes:Jan P. Teubner, Deniz Tümen, Arne Kandulski, Philipp Heumann, Patricia Mester, Elisabeth Aschenbrenner, Kirstin Pollinger, Manuela Gunckel, Barbara Volz, Tobias Hein, Paul L. Beltzig, Luisa Tengler, Florian Voll, Marina Kreutz, Claudia Kunst, Jan P. Nicolay, Martina Müller and Karsten Gülow

MARC

LEADER 00000caa a2200000 c 4500
001 1939738083
003 DE-627
005 20251103144211.0
007 cr uuu---uuuuu
008 251030s2025 xx |||||o 00| ||eng c
024 7 |a 10.1111/febs.70208  |2 doi 
035 |a (DE-627)1939738083 
035 |a (DE-599)KXP1939738083 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Teubner, Jan P.  |e VerfasserIn  |0 (DE-588)1380308585  |0 (DE-627)1939740339  |4 aut 
245 1 0 |a CRISPR-Cas9 screen reveals that inhibition of enhancer of zeste homolog 2 sensitizes malignant T cells to dimethyl-fumarate-induced cell death  |c Jan P. Teubner, Deniz Tümen, Arne Kandulski, Philipp Heumann, Patricia Mester, Elisabeth Aschenbrenner, Kirstin Pollinger, Manuela Gunckel, Barbara Volz, Tobias Hein, Paul L. Beltzig, Luisa Tengler, Florian Voll, Marina Kreutz, Claudia Kunst, Jan P. Nicolay, Martina Müller and Karsten Gülow 
264 1 |c 2025 
300 |a 17 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Erstmals veröffentlicht: 1. August 2025 
500 |a Gesehen am 30.10.2025 
520 |a Constitutive activation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway is a hallmark of many lymphocyte-associated cancers, including cutaneous T-cell lymphoma (CTCL) and its leukemic variant, the Sézary syndrome. Dimethyl fumarate (DMF) has been identified as a promising NF-κB-targeted therapy and has shown positive outcomes in a phase II clinical trial involving patients with Sézary syndrome. However, limited responsiveness remains a significant challenge. Through a genome-wide clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 screen, we identified enhancer of zeste homolog 2 (EZH2; also known as histone-lysine N-methyltransferase) as a critical target for enhancing DMF-induced cell death. EZH2, the catalytic subunit of Polycomb Repressive Complex 2 (PRC2), is responsible for the methylation of histone H3 (H3K27). Combining DMF with the US Food and Drug Administration (FDA)-approved EZH2 inhibitor tazemetostat significantly increases cell death in patient-derived CTCL cells, offering a promising strategy to improve therapeutic outcomes and overcome limited responsiveness to DMF. 
650 4 |a dimethyl fumarate (DMF) 
650 4 |a EZH2 
650 4 |a histone methylation 
650 4 |a lymphoma 
650 4 |a Polycomb Repressive Complex 2 (PRC2) 
700 1 |a Tümen, Deniz  |e VerfasserIn  |4 aut 
700 1 |a Kandulski, Arne  |e VerfasserIn  |4 aut 
700 1 |a Heumann, Philipp  |e VerfasserIn  |4 aut 
700 1 |a Mester, Patricia  |e VerfasserIn  |4 aut 
700 1 |a Aschenbrenner, Elisabeth  |e VerfasserIn  |4 aut 
700 1 |a Pollinger, Kirstin  |e VerfasserIn  |4 aut 
700 1 |a Gunckel, Manuela  |e VerfasserIn  |4 aut 
700 1 |a Volz, Barbara  |e VerfasserIn  |4 aut 
700 1 |a Hein, Tobias  |d 1989-  |e VerfasserIn  |0 (DE-588)120887697X  |0 (DE-627)1695832477  |4 aut 
700 1 |a Beltzig, Paul L.  |d 1995-  |e VerfasserIn  |0 (DE-588)1364687461  |0 (DE-627)1924741121  |4 aut 
700 1 |a Tengler, Luisa  |d 1994-  |e VerfasserIn  |0 (DE-588)1327057050  |0 (DE-627)1886565953  |4 aut 
700 1 |a Voll, Florian  |e VerfasserIn  |4 aut 
700 1 |a Kreutz, Marina  |e VerfasserIn  |4 aut 
700 1 |a Kunst, Claudia  |e VerfasserIn  |4 aut 
700 1 |a Nicolay, Jan Peter  |d 1981-  |e VerfasserIn  |0 (DE-588)138614474  |0 (DE-627)604867352  |0 (DE-576)308046188  |4 aut 
700 1 |a Müller-Schilling, Martina  |e VerfasserIn  |0 (DE-588)1075470811  |0 (DE-627)833291130  |0 (DE-576)184003237  |4 aut 
700 1 |a Gülow, Karsten  |e VerfasserIn  |0 (DE-588)1075033322  |0 (DE-627)832872008  |0 (DE-576)184768748  |4 aut 
773 0 8 |i Enthalten in  |a Vereinigung der Europäischen Biochemischen Gesellschaften  |t The FEBS journal  |d Oxford [u.a.] : Wiley-Blackwell, 2005  |g (2025), Seite 1-17  |h Online-Ressource  |w (DE-627)476538459  |w (DE-600)2172518-4  |w (DE-576)115515283  |x 1742-4658  |7 nnas 
773 1 8 |g year:2025  |g pages:1-17  |g extent:17  |a CRISPR-Cas9 screen reveals that inhibition of enhancer of zeste homolog 2 sensitizes malignant T cells to dimethyl-fumarate-induced cell death 
856 4 0 |u https://doi.org/10.1111/febs.70208  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/febs.70208  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20251030 
993 |a Article 
994 |a 2025 
998 |g 1075033322  |a Gülow, Karsten  |m 1075033322:Gülow, Karsten  |d 50000  |e 50000PG1075033322  |k 0/50000/  |p 18  |y j 
998 |g 138614474  |a Nicolay, Jan Peter  |m 138614474:Nicolay, Jan Peter  |d 60000  |d 61900  |e 60000PN138614474  |e 61900PN138614474  |k 0/60000/  |k 1/60000/61900/  |p 16 
998 |g 1327057050  |a Tengler, Luisa  |m 1327057050:Tengler, Luisa  |d 60000  |d 61900  |d 60000  |e 60000PT1327057050  |e 61900PT1327057050  |e 60000PT1327057050  |k 0/60000/  |k 1/60000/61900/  |k 0/60000/  |p 12 
998 |g 1364687461  |a Beltzig, Paul L.  |m 1364687461:Beltzig, Paul L.  |d 60000  |d 61900  |e 60000PB1364687461  |e 61900PB1364687461  |k 0/60000/  |k 1/60000/61900/  |p 11 
998 |g 120887697X  |a Hein, Tobias  |m 120887697X:Hein, Tobias  |d 60000  |e 60000PH120887697X  |k 0/60000/  |p 10 
999 |a KXP-PPN1939738083  |e 479458332X 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"17 S."}],"person":[{"roleDisplay":"VerfasserIn","family":"Teubner","display":"Teubner, Jan P.","role":"aut","given":"Jan P."},{"display":"Tümen, Deniz","role":"aut","given":"Deniz","roleDisplay":"VerfasserIn","family":"Tümen"},{"roleDisplay":"VerfasserIn","family":"Kandulski","given":"Arne","display":"Kandulski, Arne","role":"aut"},{"given":"Philipp","role":"aut","display":"Heumann, Philipp","roleDisplay":"VerfasserIn","family":"Heumann"},{"family":"Mester","roleDisplay":"VerfasserIn","display":"Mester, Patricia","role":"aut","given":"Patricia"},{"roleDisplay":"VerfasserIn","family":"Aschenbrenner","display":"Aschenbrenner, Elisabeth","role":"aut","given":"Elisabeth"},{"given":"Kirstin","role":"aut","display":"Pollinger, Kirstin","family":"Pollinger","roleDisplay":"VerfasserIn"},{"family":"Gunckel","roleDisplay":"VerfasserIn","given":"Manuela","role":"aut","display":"Gunckel, Manuela"},{"role":"aut","display":"Volz, Barbara","given":"Barbara","roleDisplay":"VerfasserIn","family":"Volz"},{"display":"Hein, Tobias","role":"aut","given":"Tobias","family":"Hein","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Beltzig","given":"Paul L.","role":"aut","display":"Beltzig, Paul L."},{"family":"Tengler","roleDisplay":"VerfasserIn","display":"Tengler, Luisa","role":"aut","given":"Luisa"},{"roleDisplay":"VerfasserIn","family":"Voll","role":"aut","display":"Voll, Florian","given":"Florian"},{"family":"Kreutz","roleDisplay":"VerfasserIn","given":"Marina","role":"aut","display":"Kreutz, Marina"},{"roleDisplay":"VerfasserIn","family":"Kunst","given":"Claudia","display":"Kunst, Claudia","role":"aut"},{"family":"Nicolay","roleDisplay":"VerfasserIn","role":"aut","display":"Nicolay, Jan Peter","given":"Jan Peter"},{"family":"Müller-Schilling","roleDisplay":"VerfasserIn","given":"Martina","role":"aut","display":"Müller-Schilling, Martina"},{"given":"Karsten","display":"Gülow, Karsten","role":"aut","roleDisplay":"VerfasserIn","family":"Gülow"}],"name":{"displayForm":["Jan P. Teubner, Deniz Tümen, Arne Kandulski, Philipp Heumann, Patricia Mester, Elisabeth Aschenbrenner, Kirstin Pollinger, Manuela Gunckel, Barbara Volz, Tobias Hein, Paul L. Beltzig, Luisa Tengler, Florian Voll, Marina Kreutz, Claudia Kunst, Jan P. Nicolay, Martina Müller and Karsten Gülow"]},"relHost":[{"title":[{"title_sort":"FEBS journal","title":"The FEBS journal"}],"id":{"eki":["476538459"],"doi":["10.1111/(ISSN)1742-4658"],"zdb":["2172518-4"],"issn":["1742-4658"]},"disp":"Vereinigung der Europäischen Biochemischen GesellschaftenThe FEBS journal","note":["Gesehen am 24.03.25"],"part":{"text":"(2025), Seite 1-17","pages":"1-17","year":"2025","extent":"17"},"name":{"displayForm":["Federation of European Biochemical Societies"]},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisherPlace":"Oxford [u.a.] ; Oxford [u.a.]","dateIssuedKey":"2005","dateIssuedDisp":"2005-","publisher":"Wiley-Blackwell ; Blackwell"}],"pubHistory":["272.2005 -"],"corporate":[{"roleDisplay":"VerfasserIn","display":"Vereinigung der Europäischen Biochemischen Gesellschaften","role":"aut"}],"recId":"476538459"}],"language":["eng"],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"2025"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1111/febs.70208"],"eki":["1939738083"]},"title":[{"title":"CRISPR-Cas9 screen reveals that inhibition of enhancer of zeste homolog 2 sensitizes malignant T cells to dimethyl-fumarate-induced cell death","title_sort":"CRISPR-Cas9 screen reveals that inhibition of enhancer of zeste homolog 2 sensitizes malignant T cells to dimethyl-fumarate-induced cell death"}],"recId":"1939738083","note":["Erstmals veröffentlicht: 1. August 2025","Gesehen am 30.10.2025"]} 
SRT |a TEUBNERJANCRISPRCAS92025